SHL Medical Launches Dynamic Webpage for Molly Autoinjector Technology

SHL Medical, a leading solutions provider in the design, development, and manufacturing of self-injection technologies, announced the launch of its Molly autoinjector webpage.

The newly launched webpage features the Molly modular platform technology, one of SHL’s most significant device offerings that are leading the market today. The page offers its visitors a three-dimensional experience brought about by its animated parallax scrolling effect. It details the entire Molly device offering, covering customizable device designs, flexible and scalable production infrastructures, as well as constant modular expansions to the Molly ecosystem that cover digital health and sustainability. The webpage is the culmination of research and discussions with various SHL subject-matter experts knowledgeable about the device technology.

“Drawing from the successes of its originally preconfigured platform predecessor, this new generation of Molly incorporates modularity across the combination product development stream. With this new Molly microsite, the industry can gain an in-depth understanding of our modular platform device technology that goes beyond the confines of platform conventionality. SHL Medical is truly proud to share this dynamic Molly webpage for the general audience to explore and learn more about the technology up close,” SHL Medical Director of Marketing Magnus Fastmarken said.

Alternatively, visitors can access the microsite via

About SHL Medical

SHL Medical is a world-leading solutions provider in the design, development, and manufacturing of advanced delivery devices such as autoinjectors, pen injectors, and wearable drug delivery systems. We offer final assembly, labeling, and packaging solutions for our drug delivery devices, and also provide contract manufacturing and engineering services for the production of complex medtech and industrial products.

With locations in Switzerland, Taiwan, Sweden, and the US, our experienced designers and engineers develop product enhancements and breakthrough drug delivery solutions for pharma and biotech clients globally. Significant investments in R&D have enhanced our broad pipeline of next-generation drug delivery systems that support ongoing innovations in drug development and digital healthcare. This includes advanced reusable and disposable injectors that can accommodate high-volume and high-viscosity formulations and can be enhanced through digital implementations.

For additional information, visit

Media contact: [email protected]